Immatics N.V.
IMTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001809196
In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Immatics N.V. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 77 | 90 | +13 |
| Shares | 71.3M | 76.6M | +5.36M (+7.5%) |
| Value | $748.9M | $890.3M | +$141.4M (+18.9%) |
New holders (23)
Institutions that held Immatics N.V. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (10)
Institutions that held Immatics N.V. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| VR Adviser, LLC | 1,750,000 | $18.4M |
| Logos Global Management LP | 1,000,000 | $10.5M |
| Rock Springs Capital Management LP | 848,751 | $8.92M |
| Alyeska Investment Group, L.P. | 470,285 | $4.94M |
| Hudson Bay Capital Management LP | 225,023 | $2.36M |
| ExodusPoint Capital Management, LP | 24,437 | $257.0K |
| Squarepoint Ops LLC | 19,043 | $200.1K |
| ADAR1 Capital Management, LLC | 16,200 | $170.3K |
| Tower Research Capital LLC (TRC) | 2,967 | $31.2K |
| Simplex Trading, LLC | 1,874 | $19.0K |